Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]
JGF Cleland, JC Daubert, E Erdmann… - European heart …, 2006 - academic.oup.com
Abstract Aims The CArdiac REsynchronization-Heart Failure study randomized patients with
left ventricular ejection fraction≤ 35%, markers of cardiac dyssynchrony, and persistent …
left ventricular ejection fraction≤ 35%, markers of cardiac dyssynchrony, and persistent …
[引用][C] Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the Cardiac REsynchronization-Heart Failure (CARE-HF) trial extension …
LA SAXON, JGF CLELAND, JC DAUBERT… - European heart …, 2006 - pascal-francis.inist.fr
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the
Cardiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Commentary …
Cardiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Commentary …
[PDF][PDF] Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension …
JGF Cleland, JC Daubert, E Erdmann… - European Heart …, 2006 - academia.edu
Aims The CArdiac REsynchronization-Heart Failure study randomized patients with left
ventricular ejection fraction 35%, markers of cardiac dyssynchrony, and persistent moderate …
ventricular ejection fraction 35%, markers of cardiac dyssynchrony, and persistent moderate …
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]
JGF Cleland, JC Daubert, E Erdmann… - European Heart …, 2006 - elibrary.ru
Aims The CArdiac REsynchronization-Heart Failure study randomized patients with left
ventricular ejection fraction? 35%, markers of cardiac dyssynchrony, and persistent …
ventricular ejection fraction? 35%, markers of cardiac dyssynchrony, and persistent …
[PDF][PDF] Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension …
JGF Cleland, JC Daubert, E Erdmann… - European Heart …, 2006 - scholar.archive.org
Aims The CArdiac REsynchronization-Heart Failure study randomized patients with left
ventricular ejection fraction 35%, markers of cardiac dyssynchrony, and persistent moderate …
ventricular ejection fraction 35%, markers of cardiac dyssynchrony, and persistent moderate …
[PDF][PDF] Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension …
JGF Cleland, JC Daubert, E Erdmann… - European Heart …, 2006 - researchgate.net
Aims The CArdiac REsynchronization-Heart Failure study randomized patients with left
ventricular ejection fraction 35%, markers of cardiac dyssynchrony, and persistent moderate …
ventricular ejection fraction 35%, markers of cardiac dyssynchrony, and persistent moderate …
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
JG Cleland, JC Daubert, E Erdmann… - European Heart …, 2006 - europepmc.org
Aims The CArdiac REsynchronization-Heart Failure study randomized patients with left
ventricular ejection fraction< or= 35%, markers of cardiac dyssynchrony, and persistent …
ventricular ejection fraction< or= 35%, markers of cardiac dyssynchrony, and persistent …
[引用][C] Longeterm effects of cardiac resynchronization therapy on mortality in heart failure (the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension …
JGF Cleland, JC Daubert, E Erdmann… - European Heart …, 2006 - research.birmingham.ac.uk
Longeterm effects of cardiac resynchronization therapy on mortality in heart failure (the CArdiac
REsynchronization-Heart Failure (CARE-HF) trial extension phase) — University of Birmingham …
REsynchronization-Heart Failure (CARE-HF) trial extension phase) — University of Birmingham …
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
JGF Cleland, JC Daubert, E Erdmann… - European Heart …, 2006 - search.ebscohost.com
Abstract Aims The CArdiac REsynchronization-Heart Failure study randomized patients with
left ventricular ejection fraction≤ 35%, markers of cardiac dyssynchrony, and persistent …
left ventricular ejection fraction≤ 35%, markers of cardiac dyssynchrony, and persistent …
[引用][C] Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension …
C JG - Eur Heart J, 2006 - cir.nii.ac.jp
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the
CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] | CiNii Research …
CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] | CiNii Research …